Publisher
Springer Science and Business Media LLC
Reference12 articles.
1. Katsumoto TR, Wilson KL, Giri VK, Zhu H, Anand S, Ramchandran KJ, et al (2022) Plasma exchange for severe immune-related adverse events from checkpoint inhibitors: an early window of opportunity? Immunother Adv 2(1):ltac012.
2. Moreira A, Loquai C, Pföhler C, Kähler KC, Knauss S, Heppt MV, et al. Myositis and neuromuscular side-effects induced by immune checkpoint inhibitors. Eur J Cancer. 2019;106:12–23.
3. Yurevitch VA, Rosenberg NK. To the question concerning washing of blood outside the body and vitality of red blood cells. Russkiy Vratch J. 1914;13:637–9.
4. Abel JJ, Rowntree LG, Turner BB. Plasma removal with return of corpuscles (plasmapheresis). J Pharmacol Exp Ther. 1914;5:625–41.
5. Brettle RP, Gross M, Legg NJ, Lockwood M, Pallis C. Treatment of acute polyneuropathy by plasma exchange. Lancet. 1978;2(8099):1100.